{"entity":{"type":"insider","cik":"0001777517","url":"/insider/0001777517","json_url":"/insider/0001777517.json","name":"Graham G. Walmsley","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":16,"first":"2020-07-21","last":"2025-03-27","span_basis":"filed_date"},"name_variants":[{"name":"Graham G. Walmsley","source":"filing","n_filings":16,"first_seen":"2020-07-21","last_seen":"2025-03-27"}],"transactions":[{"id":4417415,"accession":"0000950170-25-046271","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-046271","line_url":"/filing/0000950170-25-046271#line-3","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":43.554,"price_display":"43.55","price_state":"stated","total_value":2177700.0,"total_display":"2,177,700.00","total_whole":"2,177,700","shares_owned_after":1200000.0,"shares_owned_after_display":"1,200,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-27","filed_date":"2025-03-27","scope":"insider"},{"id":4417412,"accession":"0000950170-25-046271","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-046271","line_url":"/filing/0000950170-25-046271#line-2","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58691.0,"shares_display":"58,691","price_per_share":43.012,"price_display":"43.01","price_state":"stated","total_value":2524417.292,"total_display":"2,524,417.29","total_whole":"2,524,417","shares_owned_after":1150000.0,"shares_owned_after_display":"1,150,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-26","filed_date":"2025-03-27","scope":"insider"},{"id":4417407,"accession":"0000950170-25-046271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-046271","line_url":"/filing/0000950170-25-046271#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":91309.0,"shares_display":"91,309","price_per_share":44.747,"price_display":"44.75","price_state":"stated","total_value":4085803.823,"total_display":"4,085,803.82","total_whole":"4,085,804","shares_owned_after":1091309.0,"shares_owned_after_display":"1,091,309","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-25","filed_date":"2025-03-27","scope":"insider"},{"id":4581994,"accession":"0000950170-25-016559","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-016559","line_url":"/filing/0000950170-25-016559#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":48.0,"price_display":"48.00","price_state":"stated","total_value":9600000.0,"total_display":"9,600,000.00","total_whole":"9,600,000","shares_owned_after":1000000.0,"shares_owned_after_display":"1,000,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-30","filed_date":"2025-02-07","scope":"insider"},{"id":2765922,"accession":"0000935836-24-000763","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000935836-24-000763","line_url":"/filing/0000935836-24-000763#line-2","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700761.0,"shares_display":"700,761","price_per_share":6.75,"price_display":"6.75","price_state":"stated","total_value":4730136.75,"total_display":"4,730,136.75","total_whole":"4,730,137","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-17","filed_date":"2024-12-17","scope":"insider"},{"id":2765921,"accession":"0000935836-24-000763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000935836-24-000763","line_url":"/filing/0000935836-24-000763#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700761.0,"shares_display":"700,761","price_per_share":6.75,"price_display":"6.75","price_state":"stated","total_value":4730136.75,"total_display":"4,730,136.75","total_whole":"4,730,137","shares_owned_after":1408875.0,"shares_owned_after_display":"1,408,875","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-17","filed_date":"2024-12-17","scope":"insider"},{"id":9210428,"accession":"0000935836-24-000764","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000935836-24-000764","line_url":"/filing/0000935836-24-000764#line-2","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700761.0,"shares_display":"700,761","price_per_share":6.75,"price_display":"6.75","price_state":"stated","total_value":4730136.75,"total_display":"4,730,136.75","total_whole":"4,730,137","shares_owned_after":700761.0,"shares_owned_after_display":"700,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-13","filed_date":"2024-12-18","scope":"insider"},{"id":9210427,"accession":"0000935836-24-000764","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000935836-24-000764","line_url":"/filing/0000935836-24-000764#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700761.0,"shares_display":"700,761","price_per_share":6.75,"price_display":"6.75","price_state":"stated","total_value":4730136.75,"total_display":"4,730,136.75","total_whole":"4,730,137","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-13","filed_date":"2024-12-18","scope":"insider"},{"id":9210426,"accession":"0000935836-24-000744","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000935836-24-000744","line_url":"/filing/0000935836-24-000744","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1175000.0,"shares_display":"1,175,000","price_per_share":14.85,"price_display":"14.85","price_state":"stated","total_value":17448750.0,"total_display":"17,448,750.00","total_whole":"17,448,750","shares_owned_after":700761.0,"shares_owned_after_display":"700,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-11-26","scope":"insider","n_lines":2},{"id":2765916,"accession":"0000935836-24-000425","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000935836-24-000425","line_url":"/filing/0000935836-24-000425","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1175000.0,"shares_display":"1,175,000","price_per_share":14.85,"price_display":"14.85","price_state":"stated","total_value":17448750.0,"total_display":"17,448,750.00","total_whole":"17,448,750","shares_owned_after":700761.0,"shares_owned_after_display":"700,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-06","scope":"insider","n_lines":2},{"id":8400444,"accession":"0000950170-23-069509","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-069509","line_url":"/filing/0000950170-23-069509","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":19.8294,"price_display":"19.83","price_state":"stated","total_value":1982940.0,"total_display":"1,982,940.00","total_whole":"1,982,940","shares_owned_after":800000.0,"shares_owned_after_display":"800,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-08","filed_date":"2023-12-11","scope":"insider","n_lines":2},{"id":7856936,"accession":"0000935836-23-000733","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000935836-23-000733","line_url":"/filing/0000935836-23-000733","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":131870.0,"shares_display":"131,870","price_per_share":14.190341025252142,"price_display":"14.19","price_state":"stated","total_value":1871280.271,"total_display":"1,871,280.27","total_whole":"1,871,280","shares_owned_after":1750000.0,"shares_owned_after_display":"1,750,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-18","scope":"insider","n_lines":3},{"id":8750079,"accession":"0000950170-23-067951","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-067951","line_url":"/filing/0000950170-23-067951#line-2","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":16.9946,"price_display":"16.99","price_state":"stated","total_value":849730.0,"total_display":"849,730.00","total_whole":"849,730","shares_owned_after":700000.0,"shares_owned_after_display":"700,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-01","filed_date":"2023-12-05","scope":"insider"},{"id":8750076,"accession":"0000950170-23-067951","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-067951","line_url":"/filing/0000950170-23-067951#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":16.8967,"price_display":"16.90","price_state":"stated","total_value":844835.0,"total_display":"844,835.00","total_whole":"844,835","shares_owned_after":650000.0,"shares_owned_after_display":"650,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2023-12-05","scope":"insider"},{"id":7856923,"accession":"0000935836-23-000733","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000935836-23-000733","line_url":"/filing/0000935836-23-000733#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":508130.0,"shares_display":"508,130","price_per_share":9.84,"price_display":"9.84","price_state":"stated","total_value":4999999.2,"total_display":"4,999,999.20","total_whole":"4,999,999","shares_owned_after":1668130.0,"shares_owned_after_display":"1,668,130","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-12","filed_date":"2023-12-18","scope":"insider"},{"id":8695464,"accession":"0000950170-23-041440","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-041440","line_url":"/filing/0000950170-23-041440#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":42.059,"price_display":"42.06","price_state":"stated","total_value":1051475.0,"total_display":"1,051,475.00","total_whole":"1,051,475","shares_owned_after":600000.0,"shares_owned_after_display":"600,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-08","filed_date":"2023-08-10","scope":"insider"},{"id":8670851,"accession":"0000950170-23-036694","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-036694","line_url":"/filing/0000950170-23-036694#line-2","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":43.261,"price_display":"43.26","price_state":"stated","total_value":1081525.0,"total_display":"1,081,525.00","total_whole":"1,081,525","shares_owned_after":575000.0,"shares_owned_after_display":"575,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-01","scope":"insider"},{"id":8670848,"accession":"0000950170-23-036694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-036694","line_url":"/filing/0000950170-23-036694#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":42.6903,"price_display":"42.69","price_state":"stated","total_value":1280709.0,"total_display":"1,280,709.00","total_whole":"1,280,709","shares_owned_after":550000.0,"shares_owned_after_display":"550,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-28","filed_date":"2023-08-01","scope":"insider"},{"id":9205364,"accession":"0000899243-23-015665","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-015665","line_url":"/filing/0000899243-23-015665#line-2","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":120000.0,"shares_display":"120,000","price_per_share":42.0,"price_display":"42.00","price_state":"stated","total_value":5040000.0,"total_display":"5,040,000.00","total_whole":"5,040,000","shares_owned_after":520000.0,"shares_owned_after_display":"520,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-19","filed_date":"2023-06-15","scope":"insider"},{"id":8399905,"accession":"0000950170-23-023738","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-023738","line_url":"/filing/0000950170-23-023738#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":120000.0,"shares_display":"120,000","price_per_share":42.0,"price_display":"42.00","price_state":"stated","total_value":5040000.0,"total_display":"5,040,000.00","total_whole":"5,040,000","shares_owned_after":520000.0,"shares_owned_after_display":"520,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-19","filed_date":"2023-05-23","scope":"insider"},{"id":9205363,"accession":"0000899243-23-015665","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-015665","line_url":"/filing/0000899243-23-015665#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":10400000.0,"total_display":"10,400,000.00","total_whole":"10,400,000","shares_owned_after":400000.0,"shares_owned_after_display":"400,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-19","filed_date":"2023-06-15","scope":"insider"},{"id":2685345,"accession":"0000899243-20-033928","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-033928","line_url":"/filing/0000899243-20-033928#line-1","is_derivative":false,"issuer_cik":"0001777517","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001777517","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":76.0,"price_display":"76.00","price_state":"stated","total_value":1520000.0,"total_display":"1,520,000.00","total_whole":"1,520,000","shares_owned_after":995000.0,"shares_owned_after_display":"995,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-15","scope":"insider"},{"id":3095380,"accession":"0001209191-20-059979","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-059979","line_url":"/filing/0001209191-20-059979#line-3","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1160000.0,"shares_display":"1,160,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":22040000.0,"total_display":"22,040,000.00","total_whole":"22,040,000","shares_owned_after":1160000.0,"shares_owned_after_display":"1,160,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-11-23","scope":"insider"},{"id":2040020,"accession":"0000899243-20-019913","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-019913","line_url":"/filing/0000899243-20-019913#line-2","is_derivative":false,"issuer_cik":"0001777517","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001777517","owner_cik":"0001777517","owner_name":"Graham G. Walmsley","owner_display_name":"Graham G. Walmsley","owner_url":"/insider/0001777517","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":975000.0,"shares_display":"975,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":18525000.0,"total_display":"18,525,000.00","total_whole":"18,525,000","shares_owned_after":975000.0,"shares_owned_after_display":"975,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-21","filed_date":"2020-07-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":24,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001744659","name":"Akero Therapeutics, Inc.","url":"/issuer/0001744659","role":"Director","n_filings":8,"first_seen":"2023-05-23","last_seen":"2025-03-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001750284","name":"Olema Pharmaceuticals, Inc.","url":"/issuer/0001750284","role":"Director","n_filings":6,"first_seen":"2020-11-23","last_seen":"2024-12-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001810182","name":"ALX ONCOLOGY HOLDINGS INC","url":"/issuer/0001810182","role":"Director","n_filings":2,"first_seen":"2020-07-21","last_seen":"2020-12-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001777517","retrieved_at":"2026-08-23T00:54:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}